RPTOR and neoplasm: In contrast, tumor cell BODIPY-C16 uptake was unaffected by VEGF-B with Rptor-KO endothelial cells (Figure 3, B and C), indicating the requirement of mTORC1 activity to support transendothelial fatty acid delivery.